125 related articles for article (PubMed ID: 23809816)
1. Plasmapheresis in healthy donors in the Netherlands: cohort study of risk factors for donor complications.
Wiersum-Osselton JC; Marijt-van der Kreek T; van Dongen R
Transfus Apher Sci; 2013 Apr; 48(2):163. PubMed ID: 23809816
[No Abstract] [Full Text] [Related]
2. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
[TBL] [Abstract][Full Text] [Related]
3. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
[TBL] [Abstract][Full Text] [Related]
4. [Blood coagulation and fibrinolysis in blood donors after plasmapheresis].
Zukowska B; Kotschy M
Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):120-2. PubMed ID: 1437797
[TBL] [Abstract][Full Text] [Related]
5. A prospective trial assessing the safety and efficacy of collecting up to 840 mL of plasma in conjunction with saline infusion during plasmapheresis.
Buzza M; Marks DC; Capper H; Cassin E; Badcock CA; Reid S; Kwok M; Yang H; Lee J; Corrigan C; Hartkopf-Theis T; Keller A
Transfusion; 2012 Aug; 52(8):1806-13. PubMed ID: 22348664
[TBL] [Abstract][Full Text] [Related]
6. An extensive study of donor plasmapheresis using a membrane method by the special study group of the Japanese Red Cross Society.
Ikeda H; Tomono T; Sakai E; Endo N; Yokoyama S; Ogawa M; Shiraki H; Kameko S; Sekiguchi S
Prog Clin Biol Res; 1990; 337():503-6. PubMed ID: 2112757
[No Abstract] [Full Text] [Related]
7. Donor safety in plasmapheresis.
Lundsgaard-Hansen P
Dev Biol Stand; 1980; 48():287-95. PubMed ID: 7274560
[TBL] [Abstract][Full Text] [Related]
8. Current plasmapheresis practices in the United States.
Crispen JF
Dev Biol Stand; 1980; 48():297-301. PubMed ID: 7274561
[No Abstract] [Full Text] [Related]
9. Anticoagulation, bleeding, and clotting at donor plasmapheresis.
Evers J; Taborski U
J Clin Apher; 2018 Aug; 33(4):538-540. PubMed ID: 29575131
[TBL] [Abstract][Full Text] [Related]
10. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
[TBL] [Abstract][Full Text] [Related]
11. Plasmapheresis and clotting activation.
Vrielink H; Karssing W; de Korte D; Koopman R
Transfus Apher Sci; 2013 Apr; 48(2):157. PubMed ID: 23809813
[No Abstract] [Full Text] [Related]
12. Observation of the changes of plasma proteins after long term plasmapheresis.
Grgicević D; Pistotnik M; Pende B
Dev Biol Stand; 1980; 48():279-86. PubMed ID: 6168506
[TBL] [Abstract][Full Text] [Related]
13. Adverse reactions in healthy blood donors undergoing plasmapheresis.
Schroeder ML; Buskard N; Herbert M; Kelton J; Rock G; Sternbach M
Prog Clin Biol Res; 1990; 337():485-6. PubMed ID: 2353009
[No Abstract] [Full Text] [Related]
14. [The electrolyte content of donor blood in frequently repeated plasmapheresis].
Gutnik RB; Zinevich AK
Vrach Delo; 1968 Feb; 2():150-1. PubMed ID: 5669350
[No Abstract] [Full Text] [Related]
15. The role of commercial plasmapheresis banks on the AIDS epidemic in Mexico.
Volkow P; Perez-Padilla R; del-Rio C; Mohar A
Rev Invest Clin; 1998; 50(3):221-6. PubMed ID: 9763887
[TBL] [Abstract][Full Text] [Related]
16. Additional standards for human blood and blood products; source plasma (human)--Food and Drug Administration. Final rule.
Fed Regist; 1981 Nov; 46(226):57480-1. PubMed ID: 10253366
[TBL] [Abstract][Full Text] [Related]
17. [The apheresis: plasmapheresis, plateletpheresis, leukapheresis. Physiopathology of the donor (author's transl)].
Avanzi G
Pathologica; 1978; 70(1007-1008):467-80. PubMed ID: 370755
[No Abstract] [Full Text] [Related]
18. Plasma collection and donor safety in rural China.
Dodd RY
J Infect Dis; 2005 Nov; 192(10):1681-2. PubMed ID: 16235163
[No Abstract] [Full Text] [Related]
19. Maximum donation volumes per session in donor plasmapheresis.
Karger R; Kretschmer V
Vox Sang; 2006 Nov; 91(4):350; author reply 351-2. PubMed ID: 17105614
[No Abstract] [Full Text] [Related]
20. Plasmapheresis operations in the United States--1968.
Hartney JB
JAMA; 1970 Aug; 213(6):1023-5. PubMed ID: 5468172
[No Abstract] [Full Text] [Related]
[Next] [New Search]
